Borghi C - Search Results

1

Lipid-lowering treatment in patients at high cardiovascular risk discharged from an Italian hospital.

Spighi A, Tartagni E, D'Addato S, Dormi A, Borghi C. Spighi A, et al. Among authors: borghi c. J Cardiovasc Med (Hagerstown). 2013 Apr;14(4):270-5. doi: 10.2459/JCM.0b013e328355fae8. J Cardiovasc Med (Hagerstown). 2013. PMID: 22728834

2

Use of statins and blood pressure control in treated hypertensive patients with hypercholesterolemia.

Borghi C, Prandin MG, Costa FV, Bacchelli S, Degli Esposti D, Ambrosioni E. Borghi C, et al. J Cardiovasc Pharmacol. 2000 Apr;35(4):549-55. doi: 10.1097/00005344-200004000-00006. J Cardiovasc Pharmacol. 2000. PMID: 10774784 Clinical Trial.

3

Statins and blood pressure regulation.

Borghi C, Veronesi M, Prandin MG, Dormi A, Ambrosioni E. Borghi C, et al. Curr Hypertens Rep. 2001 Aug;3(4):281-8. doi: 10.1007/s11906-001-0090-y. Curr Hypertens Rep. 2001. PMID: 11470010 Review.

4

Use of lipid-lowering drugs and blood pressure control in patients with arterial hypertension.

Borghi C, Dormi A, Veronesi M, Immordino V, Ambrosioni E. Borghi C, et al. J Clin Hypertens (Greenwich). 2002 Jul-Aug;4(4):277-85. doi: 10.1111/j.1524-6175.2002.00499.x. J Clin Hypertens (Greenwich). 2002. PMID: 12147931 Free PMC article. Review.

5

Relative role of systolic, diastolic and pulse pressure as risk factors for cardiovascular events in the Brisighella Heart Study.

Borghi C, Dormi A, Ambrosioni E, Gaddi A; Brisighella Heart Study working party. Borghi C, et al. J Hypertens. 2002 Sep;20(9):1737-42. doi: 10.1097/00004872-200209000-00016. J Hypertens. 2002. PMID: 12195113

6

The relationship between systolic blood pressure and cardiovascular risk--results of the Brisighella Heart Study.

Borghi C, Dormi A, L'Italien G, Lapuerta P, Franklin SS, Collatina S, Gaddi A. Borghi C, et al. J Clin Hypertens (Greenwich). 2003 Jan-Feb;5(1):47-52. doi: 10.1111/j.1524-6175.2003.01222.x. J Clin Hypertens (Greenwich). 2003. PMID: 12556653 Free PMC article.

7

Improved tolerability of the dihydropyridine calcium-channel antagonist lercanidipine: the lercanidipine challenge trial.

Borghi C, Prandin MG, Dormi A, Ambrosioni E; Study Group of the Regional Unit of the Italian Society of Hypertension. Borghi C, et al. Blood Press Suppl. 2003 May;1:14-21. doi: 10.1080/08038020310000087. Blood Press Suppl. 2003. PMID: 12800983 Clinical Trial.

8

Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study.

Borghi C, Dormi A, Veronesi M, Sangiorgi Z, Gaddi A; Brisighella Heart Study Working Party. Borghi C, et al. Am Heart J. 2004 Aug;148(2):285-92. doi: 10.1016/j.ahj.2004.02.003. Am Heart J. 2004. PMID: 15308998 Clinical Trial.

9

Trends in blood pressure control and antihypertensive treatment in clinical practice: the Brisighella Heart Study.

Borghi C, Dormi A, D'Addato S, Gaddi A, Ambrosioni E; Brisighella Heart Study Working Party. Borghi C, et al. J Hypertens. 2004 Sep;22(9):1707-16. doi: 10.1097/00004872-200409000-00014. J Hypertens. 2004. PMID: 15311098 Clinical Trial.

10

Detection of familial combined hyperlipoproteinaemia patients in the Brisighella Heart Study historical cohort: an epidemiological approach.

Cicero AF, Manca M, Bove M, Dormi A, Borghi C, Gaddi AV; Brisighella Heart Study group. Cicero AF, et al. Among authors: borghi c. J Inherit Metab Dis. 2007 Apr;30(2):268. doi: 10.1007/s10545-007-0372-x. Epub 2007 Mar 8. J Inherit Metab Dis. 2007. PMID: 17347918 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

895 results

Search Page

Filters